Wilson disease;Maladie de Wilson

Presse Medicale

Volumn 38, Issue 7-8, 2009, Pages 1089-1098

  Trocello, Jean Marc ^a   Chappuis, Philippe ^a   Chaine, Pascal ^a   Rémy, Pascal ^a   Debray, Dominique ^b   Duclos Vallée, Jean Charles ^c   Woimant, France ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b BICÊTRE HOSPITAL   (France)

^c HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT; COPPER; PENICILLAMINE; TRIENTINE; UNCLASSIFIED DRUG; WILSON DISEASE PROTEIN; WILZIN; ZINC DERIVATIVE;

CLINICAL FEATURE; COPPER BLOOD LEVEL; COPPER METABOLISM; DISEASE REGISTRY; DRUG EFFICACY; FOLLOW UP; GENETIC POLYMORPHISM; HUMAN; LABORATORY TEST; LIVER TRANSPLANTATION; LONG TERM CARE; MOLECULAR BIOLOGY; MUTATIONAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PATIENT MONITORING; PROTEIN TRANSPORT; SHORT SURVEY; WILSON DISEASE;

ADENOSINE TRIPHOSPHATASES; BRAIN; CATION TRANSPORT PROTEINS; CHELATING AGENTS; COPPER; DISCLOSURE; HEPATOCYTES; HEPATOLENTICULAR DEGENERATION; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MOLECULAR CHAPERONES; MONITORING, PHYSIOLOGIC; PATIENT CARE TEAM; PENICILLAMINE; PHENOTYPE; REGISTRIES; RNA, MESSENGER; ZINC;

EID: 67649574120     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2008.11.017     Document Type: Short Survey

References (36)

1. Haute Autorité de Santé. Protocole national de diagnostic et de soins. Maladie de Wilson. 2008. http://www.has-sante.fr/portail/jcms/c_640052/ald-n-17-maladie-de-wilson (consulté le 15 janvier 2009).
2. Roberts E.A., and Schilsky M.L. American association for study of liver diseases (AASLD). Diagnosis and treatment of Wilson disease: an update. Hepatology 47 (2008) 2089-2111
3. Lutsenko S., Barnes N.L., Bartee M.Y., and Dmitriev O.Y. Function and Regulation of Human Copper-Transporting ATPases. Physiol Rev 87 (2007) 1011-1046
4. Barnes N., Tsivkovskii R., Tsivkovskaia N., and Lutsenko S. The copper-transporting ATPases, menkes and wilson disease proteins, have distinct roles in adult and developing cerebellum. J Biol Chem 280 (2005) 9640-9645
5. Chappuis P., Bost M., Misrahi M., Duclos-Vallée J.C., and Woimant F. Exploration biologique de la maladie de Wilson. Ann Biol Clin (Paris) 63 (2005) 457-466
6. Sheline C.T., and Choi D.W. Cu2+ toxicity inhibition of mitochondrial dehydrogenases in vitro and in vivo. Ann Neurol 55 (2004) 645-653
7. Mufti A.R., Burstein E., Csomos R.A., Graf P.C., Wilkinson J.C., Dick R.D., et al. XIAP Is a copper binding protein deregulated in Wilson's disease and other copper toxicosis disorders. Mol Cell 21 (2006) 775-785
8. Huster D., Finegold M.J., Morgan C.T., Burkhead J.L., Nixon R., Vanderwerf S.M., et al. Consequences of copper accumulation in the livers of the Atp7b-/- (Wilson disease gene) knockout mice. Am J Pathol 168 (2006) 423-434
9. Huster D., Purnat T.D., Burkhead J.L., Ralle M., Fiehn O., Stuckert F., et al. High copper selectively alters lipid metabolism and cell cycle machinery in the mouse model of Wilson disease. J Biol Chem 282 (2007) 8343-8355
10. Achila D., Banci L., Bertini I., Bunce J., Ciofi-Baffoni S., and Huffman D.L. Structure of human Wilson protein domains 5 and 6 and their interplay with domain 4 and the copper chaperonne HAH1 in copper uptake. Proc Natl Acad Sci USA 103 (2006) 5729-5734
11. Thomas G.R., Roberts E.A., Walshe J.M., and Cox D.W. Haplotypes and mutations in Wilson disease. Am J Hum Genet 56 (1995) 1315-1319
12. de Bie P., van de Sluis B., Burstein E., van de Berghe P.V., Muller P., Berger R., et al. Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B. Gastroenterology 133 (2007) 1316-1326
13. Merle U., Stremmel W., and Gessner R. Influence of homozygosity for methionine at codon 129 of the human prion gene on the onset of neurological and hepatic symptoms in Wilson disease. Arch Neurol 63 (2006) 982-985
14. Schiefermeier M., Kollegger H., Madl C., Polli C., Oder W., Kühn H., et al. The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease. Brain 123 (2000) 585-590
15. Woimant F., Chaine P., Favrole P., Mikol J., and Chappuis P. Mise au point. La maladie de Wilson. Rev Neurol (Paris) 162 (2006) 773-781
16. Ingster-Moati I., Bui Quoc E., Pless M., Djomby R., Orssaud C., Guichard J.P., et al. Ocular motility and Wilson's disease: a study on 34 patients. J Neurol Neurosurg Psychiatry 78 (2007) 1199-1201
17. Shanmugiah A., Sinha S., Taly A.B., Prashanth L.K., Tomar M., Arunodaya G.R., et al. Psychiatric manifestations in Wilson's disease: a cross-sectional analysis. J Neuropsychiatry Clin Neurosci 20 (2008) 81-85
18. Suvarna J.C. Kayser-Fleischer ring. J Postgrad Med 54 (2008) 238-240
19. Członkowska A., Rodo M., and Gromadzka G. Late onset Wilson's disease: therapeutic implications. Mov Disord 23 (2008) 896-898
20. Steindl P., Ferenci P., Dienes H.P., Grimm G., Pabinger I., Madl C., et al. Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology 113 (1997) 212-218
21. Twomey P.J., Viljoen A., Reynolds T.M., and Wierzbicki A.S. Non-ceruloplasmin-bound copper in routine clinical practice in different laboratories. J Trace Elem Med Biol 22 (2008) 50-53
22. Ala A., Walker A.P., Ashkan K., Dooley J.S., and Schilsky M.L. Wilson's disease. Lancet 369 (2007) 397-408
23. Foruny J.R., Boixeda D., López-Sanroman A., Vázquez-Sequeiros E., Villafruela M., Vázquez-Romero M., et al. Usefulness of penicillamine-stimulated urinary copper excretion in the diagnosis of adult Wilson's disease. Scand J Gastroenterol 43 (2008) 597-603
24. Grimm G., Prayer L., Oder W., Ferenci P., Madl C., Knoflach P., et al. Comparison of functional and structural brain disturbances in Wilson's disease. Neurology. 41 (1991) 272-276
25. Favrole P., Chabriat H., Guichard J.P., and Woimant F. Clinical correlates of cerebral water diffusion in Wilson disease. Neurology 66 (2006) 384-389
26. Hsi G., Cullen L.M., Mc Intyre G., Chen M.M., Glerum D.M., and Cox D.W. Sequence variation in the ATP-binding domain of the Wilson Disease Transporter, ATP7B affects copper transport in a yeast model system. Hum Mutat 29 (2008) 4914-5501
27. Merle U., Schaefer M., Ferenci P., and Stremmel W. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut 56 (2007) 115-120
28. Brewer G.J., Askari F., Lorincz M.T., Carlson M., Schilsky M., Kluin K.J., et al. Treatment of Wilson disease with ammonium tetrathiomolybdate : IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease. Arch Neurol 63 (2006) 521-527
29. Ichai P., and Samuel D. Treatment of patients with hepatic failure: the difficult place of liver support systems. J Hepatol 41 (2004) 694-695
30. Pabón V., Dumortier J., Gincul R., Baulieux J., Ducerf C., Trépo C., et al. Long-term results of liver transplantation for Wilson's disease. Gastroenterol Clin Biol 32 (2008) 378-381
31. Medici V., Mirante V.G., Fassati L.R., Pompili M., Forti D., Del Gaudio M., et al., Monotematica AISF 2000 OLT study group. Liver transplantation for Wilson's disease: the burden of neurological and psychiatric disorders. Liver Transpl 11 (2005) 1056-1063
32. Członkowska A., Tarnacka B., Möller J.C., Leinweber B., Bandmann O., Woimant F., et al. Unified Wilson's disease rating scale: a proposal for the neurological scoring of Wilson's disease patients. Neurol Neurochir Pol 41 (2007) 1-12
33. Walshe J.M., Waldenström E., Sams V., Nordlinder H., and Westermark K. Abdominal malignancies in patients with Wilson's disease. QJM 96 (2003) 657-662
34. Péron-Magnan T., Trocello J.M., Pernon M., de Tassigny A., and Woimant F. De la clinique à la rééducation pour un trouble de l'écriture dans la maladie de Wilson illustré par un cas clinique. Kinésithérapie scientifique 490 (2008) 29-41
35. Gravereaux M., and de Tassigny A. Le rôle des psychologues auprès de patients atteints de la maladie de Wilson. Journal des psychologues 252 (2007) 39-43
36. Leyendecker A, Pelosse M, Debray D, Parker S, Fox M, Tanner S et al. Registres sur la maladie de Wilson : de la France à l'Europe. La Lettre du neurologue 2008;12 (Suppl. 3)10:14-5.